Filing Details

Accession Number:
0001209191-14-031519
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-06 17:30:43
Reporting Period:
2014-05-02
Filing Date:
2014-05-06
Accepted Time:
2014-05-06 16:30:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554979 E Megan Pace C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp, Corp. Communications No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-05-02 500 $67.01 23,850 No 4 S Direct
Common Stock Disposition 2014-05-02 400 $67.94 23,450 No 4 S Direct
Common Stock Disposition 2014-05-02 100 $69.42 23,350 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.
  2. Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $67.01 (range $66.49 to $67.40).
  4. Open market sales reported on this line occurred at a weighted average price of $67.94 (range $67.73 to $68.24).